Increased serum carcinoembryonic antigen level can predict poor survival of patients with small cell lung cancer. (Q53518876)

15 May 2018

title

Increased serum carcinoembryonic antigen level can predict poor survival of patients with small cell lung cancer. (English)

1 reference

15 May 2018

author name string

Hui Zhu

1

1 reference

15 May 2018

Hongbo Guo

2

1 reference

15 May 2018

Minghuan Li

3

1 reference

15 May 2018

Yan Zhang

4

1 reference

15 May 2018

Anqin Han

5

1 reference

15 May 2018

Fang Shi

6

1 reference

15 May 2018

Li Kong

7

1 reference

15 May 2018

Jinming Yu

8

1 reference

15 May 2018

publication date

14 April 2015

1 reference

15 May 2018

published in

Translational Research

1 reference

15 May 2018

volume

166

1 reference

15 May 2018

issue

4

1 reference

15 May 2018

page(s)

355-365

1 reference

15 May 2018

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database

cites work

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Global cancer statistics, 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Radiotherapy for small-cell lung cancer-Where are we heading?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor for survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

The CEACAM1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of CEACAM1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Serum carcinoembryonic antigen level in non-small-cell lung cancer patients with preoperative normal serum level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

C-stage in Colon Cancer: Implications of Carcinoembryonic Antigen Biomarker in Staging, Prognosis, and Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Survival and prognostic factors in small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

CEA is an independent prognostic indicator that is associated with reduced survival and liver metastases in SCLC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Treatment modality selection and prognosis of early stage small cell lung cancer: retrospective analysis from a single cancer institute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2015.04.005

10.1016/J.TRSL.2015.04.005

7 January 2021

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018